Subscribe To
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 10:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 10:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...
December 2, 2022, 5:02 pm
Merck (mrk) keytruda advanced gastric cancer study meets goal
Top-line data from a late-stage study shows that Merck's (MRK) Keytruda combined with chemotherapy improved overall survival in patients with advanced...
November 23, 2022, 1:33 pm
Volitionrx ends q3 with $16.4 million cash, moves from r&d to commercial cancer screening company
VolitionRx (NYSE-A:VNRX) said it ended third-quarter 2022 with US$16.4 million in cash and cash equivalents, thanks to careful management of expenditu...
November 15, 2022, 9:14 am
Why macrogenics stock crushed the market on monday
Positive momentum continues for the cancer specialist in the wake of its latest earnings report....
November 14, 2022, 6:31 pm
Volitionrx teams up with leading french veterinary group to assess potential of cancer screening technology
VolitionRx (NYSE-A:VNRX) Limited said it will work with a renowned French veterinary referral clinic to further assess the potential of its ...
November 14, 2022, 9:18 am
Why shares of neogenomics jumped 53.9% this week
The cancer screening company showed its turnaround may be working....
November 11, 2022, 5:36 pm
Glycomimetics could surge if q1 data readout is positive
GlycoMimetics stock price jumped on November 9. Good cancer survival results may have lengthened the ti...
November 11, 2022, 11:22 am
Why amgen's cancer drug results gave this small cap a big boost
Amgen stock jumped Wednesday after outperforming expectations in a lung-cancer study. It brought rival ...
August 31, 2022, 12:04 pm
Soligenix shares gain on hybrytes data from blood cancer study
Soligenix Inc (NASDAQ: SNGX) announced the results of its Phase 3 FLASH study evaluating HyBryte (synthetic hypericin) for cutaneous T-cell lymphom...
July 20, 2022, 3:19 pm